±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1082  |  »Ø¸´: 1

Ãβ»Âädyn

гæ (СÓÐÃûÆø)

[ÇóÖú] ÇëÎÊ£¬ÓÐÖªµÀ±»FDAÅú×¼µÄ¿ÉÒÔÓÃÓڷβ¿¸øÒ©µÄ±íÃæ»îÐÔ¼ÁµÄÂ𣿠ÒÑÓÐ1È˲ÎÓë

ÐèÒªÕâ·½ÃæµÄÐÅÏ¢£¬µ«ÊDz»ÖªµÀÔÚÄIJéÕÒ£¬Ï£ÍûÖªµÀµÄͬ°û¿ÉÒÔÖ¸µ¼Ò»Ï£¬Íò·Ö¸Ðл£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

voyager88

½ð³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ãβ»Âädyn: ½ð±Ò+5, ¡ïÓаïÖú 2015-09-08 12:49:01
Á×Ö¬£¬ÓÍËá¶¼¿ÉÒÔʹÓã¬Ïê¼ûÎüÈë·Û¼Á£¬ÆøÎí¼ÁÐÐÒµÖ¸ÄÏ¡£µ«ÊǼ¶±ðÒªÇó½Ï¸ß£¬²»ÊÇÒ»°ãµÄÁ×Ö¬¡£ÒÔÏÂÊÇÖ¸µ¼Ô­ÔòÔ­ÎÄ£¬ÒëÎͼ¸øÄ㸽ÉÏÁË£¬ÏëÒªÕÒµ½Ô­Îļþ£¬¸´ÖÆÆäÖÐÒ»¾ä»°£¬°Ù¶È¾ÍÄܸ㶨
When Lecithin, NF, a surfactant, is used in MDI formulations, additional acceptance criteria and tests controlling the complete compositional profile should be used (e.g., levels of phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl inositol, lysophosphatidyl choline, phosphatidic acid, triglycerides, fatty acids, carbohydrates).
NFÖÐÁ×Ö¬ÊÇÒ»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦Ê¹Óøü¶àµÄÑéÊÕ±ê×¼ºÍ²âÊÔÏîÄ¿£¬ÒÔ¿ØÖÆ×é·ÖÍêÕûµÄÌØÕ÷£¨Á×Ö¬õ£µ¨¼î¡¢Á×Ö¬õ£´¼°·¡¢Á×Ö¬õ£¼¡´¼¡¢ÈÜѪÁ×Ö¬õ£µ¨¼î¡¢Á×Ö¬Ëá¡¢¸ÊÓÍÈýõ¥¡¢Ö¬·¾ËáºÍ̼ˮ»¯ºÏÎïµÈµÄˮƽ£©¡£
When Oleic Acid, NF is used as a surfactant in MDI formulations, additional specifications should be included for identification, assay, and for characterization and control of the compositional profile of impurities (e.g., individual specified fatty acids, unknowns).
NFÖÐÓÍËáÓÃ×÷Ò»ÖÖ±íÃæ»îÐÔ¼Á£¬µ±ÓÃÓÚMDIsʱ£¬Ó¦½¨Á¢½øÒ»²½¼ø¶¨¡¢º¬Á¿¡¢±íÕ÷ºÍ¿ØÖÆÔÓÖÊÆ×µÈµÄÖÊÁ¿±ê×¼£¨ÈçÓÎÀëºÍÌØÊâÖ¬·¾Ëᣬδ֪Î¡£
΢ÐŹ«ÖںţºPharmaguider£¨Ò©ÊÂ×ݺᣩ£¬Ö÷Ò³£ºwww.pharmaguider.cn
2Â¥2015-09-08 11:13:06
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Ãβ»Âädyn µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á +11 lyz0427 2026-04-03 11/550 2026-04-04 15:31 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ²ÄÁϹ¤³Ì085601£¬Çóµ÷¼Á +17 cdyw 2026-04-02 18/900 2026-04-04 11:14 by w_xuqing
[¿¼ÑÐ] 322Çóµ÷¼Á +4 FZAC123 2026-04-03 4/200 2026-04-03 20:55 by zhq0425
[¿¼ÑÐ] 336Çóµ÷¼Á +8 kiyy 2026-04-01 8/400 2026-04-03 19:41 by lijunpoly
[¿¼ÑÐ] 338Çóµ÷¼Á +4 êɹ¦? 2026-04-03 4/200 2026-04-03 14:01 by °ÙÁéͯ888
[¿¼ÑÐ] ר˶085601Çóµ÷¼Á +7 suyifei 2026-04-03 8/400 2026-04-03 14:00 by ÐÀϲ777
[¿¼ÑÐ] Ò»Ö¾Ô¸°²»Õ´óѧ0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á +14 ÎÒ²»ÊÇÖ»Òò 2026-04-02 15/750 2026-04-03 09:49 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 260Çóµ÷¼Á +6 ÖìÜÆÁÕ 2026-04-02 6/300 2026-04-02 20:27 by 6781022
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©Àí¹¤´óѧ±¾¿Æ211²ÄÁϹ¤³Ì294Çóµ÷¼Á +8 mikasaµÄΧ½í 2026-03-28 9/450 2026-04-02 12:09 by ms629
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] ¿¼Ñе÷¼Á +12 Amber00 2026-03-31 12/600 2026-04-02 09:04 by sanrepian
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-03-31 11/550 2026-04-01 22:25 by zhouyuwinner
[¿¼ÑÐ] 298Çóµ÷¼Á +4 ʲôÊÇÅÖÍ·Óã 2026-03-30 6/300 2026-04-01 22:06 by ¿Í¶ûÃÀµÂ
[¿¼ÑÐ] 290Çóµ÷¼Á +5 dfffsar 2026-03-29 5/250 2026-04-01 19:45 by 6781022
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +7 Ë«ÂíβƦÀϰå2 2026-03-31 7/350 2026-03-31 19:49 by Dyhoer
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 hyl3153942 2026-03-29 10/500 2026-03-31 16:31 by hypershenger
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó²ÄÁÏ357 +4 Âó¶÷Àò. 2026-03-30 4/200 2026-03-31 14:35 by ¼Çʱ¾2026
[¿¼ÑÐ] Ó¢Ò»ÊýÒ»×Ü·Ö334Çóµ÷¼Á +4 ³ÂÑôÀ¤ 2026-03-31 4/200 2026-03-31 14:22 by ¼Çʱ¾2026
[¿¼ÑÐ] 313Çóµ÷¼Á +6 Âô¸ö¹Ø×Ó°É 2026-03-31 6/300 2026-03-31 10:58 by Jaylen.
[¿¼ÑÐ] 279Çóµ÷¼Á +12 jµÄÁ¢·½ 2026-03-29 12/600 2026-03-30 20:30 by dick_runner
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û